Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pediatric acute leukemia therapies informed by molecular analysis of high-risk disease.

Hematology. American Society of Hematology. Education Program - 1 Jan 2011

Winter Stuart S

Abstract excerpt

The acute leukemias are the most common cancer of children, adolescents, and young adults. These diseases are characterized by a tremendous variability in clinical course, prompting a continuing search for accurate predictors of outcome. Using algorithms based on clinical features at presentation, response to therapy, and several molecular analyses, some patients are diagnosed with features of high-risk disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Leukemia
Share to Phenotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Protein Kinases

Share to Recurrence

Share to Risk Factors

Share to Signal Transduction

Source

Identifiers

PMID: 22160059
DOI: 10.1182/asheducation-2011.1.366

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pediatric acute leukemia therapies informed by molecular analysis of high-risk disease.PMID 22160059Read ↗

Biology, risk stratification, and therapy of pediatric acute leukemias: an update.Semantic proximity Read ↗

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?Semantic proximity Read ↗

Evolving treatment strategies in patients with high-risk acute myeloid leukemia.Semantic proximity Read ↗

Toward Individualized Therapy in Acute Myeloid Leukemia: A Contemporary Review.Semantic proximity Read ↗

Advances in the molecular genetics of acute leukemia.Semantic proximity Read ↗

Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia.Semantic proximity Read ↗

Progress and Prospects in Pediatric Leukemia.Semantic proximity Read ↗

Pediatric acute myeloid leukemia tumor composition predicts patient outcomes at diagnosis and reveals mechanisms of resistance to chemotherapySemantic proximity Read ↗

Treatment of acute myeloid leukemia in children: A practical perspective.Semantic proximity Read ↗

Acute Myeloid Leukemia: Biologic, Prognostic, and Therapeutic Insights.Semantic proximity Read ↗

Treatment Approaches in Pediatric Acute Myeloid Leukemia: A Narrative ReviewSemantic proximity Read ↗

Pediatric Mixed-Phenotype Acute Leukemia: What’s New?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.